Literature DB >> 11459221

Comparative studies on the GABA-transaminase immunoreactivity in rat and gerbil brains.

T C Kang1, S K Park, J H Bahn, J S Chang, S W Cho, S Y Choi, M H Won.   

Abstract

Gamma-aminobutyric acid (GABA) is the most important inhibitory neurotransmitter in the central nervous system (CNS). Degradation of GABA in the CNS is catalyzed by the action of GABA transaminase (GABA-T). However, the neuroanatomical characteristics of GABA-T in the gerbil, which is a useful experimental animal in neuroscience, are still unknown. Therefore, we performed a comparative analysis of the distribution of GABA-T in rat and gerbil brains using immunohistochemistry. GABA-T immunoreactive neurons were observed in the regions which contained GABAergic neurons of both animals: corpus striatum; substantia nigra, pars reticulata; septal nucleus; and accumbens nucleus. GABA-T + neurons were restricted to layers III and V in the rat. Unlike the rat GABA-T + neurons were observed in layers II, III, and V of the gerbil cerebral cortex. These results suggest that the expression of GABA-T in the gerbil brain may be similar to that in the rat brain, except in the cerebral cortex.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11459221

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  2 in total

1.  Gamma-vinyl GABA inhibits cocaine-triggered reinstatement of drug-seeking behavior in rats by a non-dopaminergic mechanism.

Authors:  Xiao-Qing Peng; Xia Li; Jeremy G Gilbert; Arlene C Pak; Charles R Ashby; Jonathan D Brodie; Stephen L Dewey; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

2.  Neurodegeneration, Myelin Loss and Glial Response in the Three-Vessel Global Ischemia Model in Rat.

Authors:  Tatiana Anan'ina; Alena Kisel; Marina Kudabaeva; Galina Chernysheva; Vera Smolyakova; Konstantin Usov; Elena Krutenkova; Mark Plotnikov; Marina Khodanovich
Journal:  Int J Mol Sci       Date:  2020-08-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.